Latest Conference Articles

Oral PCSK9 Inhibitor Significantly Reduced High Levels of Cholesterol in Phase 1 Trials

Oral PCSK9 Inhibitor Significantly Reduced High Levels of Cholesterol in Phase 1 Trials

November 18th 2021

American Heart Association

AHA 2021: New research showed MK-0616, an investigative oral PCSK9 inhibitor, was associated with a near 65% decrease in LDL-C.

First Sign of CVD in Smokers May be a Fatal MI or Stroke, New Study Finds

First Sign of CVD in Smokers May be a Fatal MI or Stroke, New Study Finds

November 17th 2021

American Heart Association

Smoking was associated with earlier onset of cardiovascular disease, by 5.1 years for men and 3.8 years for women, the new study found.

Canagliflozin Improved HF Symptoms, QOL Regardless of Diabetes Status in Fully Remote Clinical Trial

Canagliflozin Improved HF Symptoms, QOL Regardless of Diabetes Status in Fully Remote Clinical Trial

November 16th 2021

American Heart Association

AHA 2021. Heart failure patients, across ejection fraction and diabetes status, reported improved QOL as early as 3 months in CHIEF-HF trial.

Remote Program Improves Blood Pressure and Cholesterol in High-risk Patients

Remote Program Improves Blood Pressure and Cholesterol in High-risk Patients

November 16th 2021

American Heart Association

AHA 2021: Study suggests remote hypertension and hyperlipidemia management programs may expand telehealth delivery, increase access to care, and reduce health inequities.

AHA 2021: Novel Fitbit Algorithm Correctly Detected Undiagnosed Atrial Fibrillation

AHA 2021: Novel Fitbit Algorithm Correctly Detected Undiagnosed Atrial Fibrillation

November 15th 2021

American Heart Association

AHA 2021: Novel software algorithm used in Fitbit wearable devices accurately detected undiagnosed atrial fibrillation about 98% of the time, showed results of the Fitbit Heart Study.

Coffee Had Negligible Effect on Atrial Arrhythmias but Was Linked to PVCs, Study Finds

Coffee Had Negligible Effect on Atrial Arrhythmias but Was Linked to PVCs, Study Finds

November 15th 2021

American Heart Association

AHA 2021. Coffee increased PVCs by 54% in regular coffee drinkers and decreased sleep by more than 30 minutes; it also significantly increased daily step count and slightly improved SVT.

Population for Digital Heart Failure Coaching App May Need Rethinking

Population for Digital Heart Failure Coaching App May Need Rethinking

November 12th 2021

American Heart Association

AHA Scientific Sessions 2021: New research provides a note of caution for the use of digital heart failure coaching apps in severely ill and elderly patients with unstable heart failure.

Study Highlights Factors that Influence Patient Engagement with Remote CVD Risk Reduction Intervention

Study Highlights Factors that Influence Patient Engagement with Remote CVD Risk Reduction Intervention

November 12th 2021

American Heart Association

AHA Scientific Sessions 2021: Employment status and higher caregiver burden were linked to increased engagement with a videoconferencing-based intervention to reduce the risk of CVD.

EHR-integrated Remote Monitoring of Hypertension: A Pilot Study in Primary Care

EHR-integrated Remote Monitoring of Hypertension: A Pilot Study in Primary Care

November 12th 2021

American Heart Association

EHR-integrated remote BP monitoring was evaluated in a primary care Medicare population to assess uptake and initial effects on hypertension management.

Automated Statin-associated Muscle Symptom Tracker May Help Tailor Therapy, Improve Adherence

Automated Statin-associated Muscle Symptom Tracker May Help Tailor Therapy, Improve Adherence

November 10th 2021

American Heart Association

AHA Scientific Sessions 2021. Statin-associated muscle symptoms complicate treatment initiation and adherence; a new mHealth tool shows promise in reducing treatment cessation.